EIN Presswire is celebrating 30 years! Follow us on Substack for customer insights, interviews, and more!

EIN Presswire is celebrating 30 years! Follow us on Substack for customer insights, interviews, and more!

World Media Directory · RSS · Email Newsletters

There were 1,804 press releases posted in the last 24 hours and 432,010 in the last 365 days.

Press Releases on August 14, 2024

1,419 Press Releases

Published on August 14, 2024 - 20:05 GMT

Ingredion Named a Finalist for the National Safety Council's Green Cross for Safety® Awards

WESTCHESTER, Ill., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage industry, has been named a finalist for the National Safety Council's (NSC) Green Cross …

Distribution channels: Food & Beverage Industry ...
Published on August 14, 2024 - 20:05 GMT

Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update

Signs non-binding term sheet granting global rights to develop and commercialize oral MAT2203 for invasive aspergillosis and potentially other invasive fungal infections 31 patients have enrolled in the MAT2203 Compassionate/Expanded Use Access Program …

Distribution channels:
Published on August 14, 2024 - 20:05 GMT

Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates

Updated clinical results from German Real-World Registry demonstrate potential for Revita® to meaningfully sustain weight loss and lower blood sugar for at least one-year post-treatment in a real-world setting Granted U.S. FDA Breakthrough Device …

Distribution channels:
Published on August 14, 2024 - 20:05 GMT

nCino Announces Timing of its Second Quarter Fiscal Year 2025 Financial Results Conference Call

WILMINGTON, N.C., Aug. 14, 2024 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking for the global financial services industry, will report financial results for its second quarter ended July 31, 2024, after the market close on …

Distribution channels: Technology ...
Published on August 14, 2024 - 20:05 GMT

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024

- Preliminary data from the Phase 1 trial of PYX-201 remains on track to be announced in the fall of 2024 - Preliminary data from the Phase 1 trial of PYX-106 is expected to be reported by year-end 2024 - Expected cash runway into 2H 2026 BOSTON, Aug. 14, …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on August 14, 2024 - 20:05 GMT

Windtree Announces New Additions and Changes to Its Board of Directors

WARRINGTON, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, …

Distribution channels: Companies, Technology ...
Published on August 14, 2024 - 20:05 GMT

LENZ Therapeutics Reports Second Quarter 2024 Financial Results

Submitted New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for LNZ100 for the treatment of presbyopia Announced positive topline and capstone data from the Phase 3 CLARITY study Strengthened financial position with $30 million …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
Published on August 14, 2024 - 20:05 GMT

GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GTB-3650 TriKE® Phase 1 trial initiation expected in 2H 2024; initial clinical data expected in 1H 2025 GTB-5550 TriKE® IND submission for treatment of B7H3 positive solid tumors expected in 1H 2025 GTB-5550 Phase 1 dose escalation basket trial initiation …

Distribution channels:
Published on August 14, 2024 - 20:05 GMT

STRATA Skin Sciences Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

HORSHAM, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of …

Distribution channels:
Published on August 14, 2024 - 20:05 GMT

Robinhood Markets, Inc. Reports July 2024 Operating Data

MENLO PARK, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported select monthly operating data for July 2024: Funded Customers at the end of July were 24.2 million (up approximately 70 thousand from …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on August 14, 2024 - 20:05 GMT

Actuate Therapeutics Announces Closing of Initial Public Offering

CHICAGO and FORT WORTH, Texas, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Nasdaq: ACTU) (the “Company”), a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat …

Distribution channels: Banking, Finance & Investment Industry, Technology ...
Published on August 14, 2024 - 20:05 GMT

Dragonfly Energy Reports Second Quarter 2024 Financial and Operational Results

Dragonfly Energy entered into a $30 million licensing agreement with Stryten Energy, a leading North American battery manufacturer, to allow for expansion of Battle Born Batteries® products into new markets The Company announced progress in bringing its …

Distribution channels: Business & Economy, Technology ...
Published on August 14, 2024 - 20:05 GMT

Fathom Holdings to Present at the 2024 Gateway Conference on September 4th

CARY, N.C., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Fathom Holdings Inc. (Nasdaq: FTHM) (“Fathom” or the “Company”), a national, technology-driven, end-to-end real estate services platform integrating residential brokerage, mortgage, title, and SaaS offerings …

Distribution channels: Banking, Finance & Investment Industry ...
Published on August 14, 2024 - 20:05 GMT

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

- Oral Fadraciclib Phase 2 Proof of Concept Study Enrolling Well - - 065-101 PoC Interim Data Anticipated in the Fourth Quarter of 2024 - - Management to Host Conference Call at 4:30 pm EDT Today - BERKELEY HEIGHTS, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on August 14, 2024 - 20:05 GMT

Longeveron® Announces Second Quarter 2024 Financial Results and Provides Business Update

Positive data from the Phase 2a clinical trial (CLEAR MIND ) evaluating Lomecel-B™ in Alzheimer’s disease presented in Featured Research Oral Presentation at Alzheimer’s Association International Conference® (AAIC) U.S. FDA granted Lomecel-B™ both …

Distribution channels:
Published on August 14, 2024 - 20:05 GMT

Jushi Holdings Inc. Announces Option Re-Pricing Program

BOCA RATON, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, is pleased to announce that its board of directors has approved an option …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on August 14, 2024 - 20:05 GMT

Parsons Unveils Updated iNET®, an AI-Enabled, SaaS Smart Mobility Solution

CHANTILLY, Va., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) today announced the launch of the newest iteration of iNET®, the company’s industry-leading intelligent transportation software. Built on the Microsoft Azure platform, the …

Distribution channels: Media, Advertising & PR ...
Published on August 14, 2024 - 20:05 GMT

Noodles Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BROOMFIELD, Colo., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Noodles & Company (NASDAQ: NDLS) (the “Company”) today announced that its Board of Directors (the “Board”) granted an equity award to Scott Davis as an equity inducement award outside of the Company’ …

Distribution channels: Food & Beverage Industry, Retail ...
Published on August 14, 2024 - 20:05 GMT

Expion360 Reports Second Quarter 2024 Financial Results

Q2 Sequential Revenue Growth of 32% with New Products and Technologies Substantial Preorders of Next Generation Group 27 & GC2 Batteries and Modular Design Edge™ Battery New Retail E-Commerce Partnership with Tractor Supply Company Closed $10 Million …

Distribution channels:
Published on August 14, 2024 - 20:05 GMT

ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Results and Provides Corporate Update

Entered into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys Significant Reduction in Overall Operating Expenses of 45.4% in the First Half of 2024 Compared to the First Half of 2023 Conference Call to be Held at 4 …

Distribution channels:

Previous 7 8 9 10 11 12 13 14 15 16 17 Next

Previous Day 2024 Calendar Next Day